| |
| |
|
| Insider
Information: |
Rolke James |
| Relationship: |
Officer, Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
763,073 |
|
|
Indirect Shares
|
2,144 |
|
|
| Direct
Value |
$713,006 |
|
|
|
Indirect Value
|
$643 |
|
|
| Total
Shares |
765,217 |
|
|
| Total
Value |
$713,649 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
La Jolla Pharmaceutical Co |
LJPC |
Chief Scientific Officer |
2020-05-29 |
81,771 |
2018-08-16 |
0 |
Premium* |
|
|
Revelation Biosciences Ord Shs |
REVB |
Officer, Director |
2022-01-10 |
681,302 |
2022-01-10 |
2,144 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REVB |
Revelation Biosciences Or... |
Chief Executive OfficerOfficer |
• • – |
2022-01-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,144 |
|
% |
|
| REVB |
Revelation Biosciences Or... |
Chief Executive OfficerOfficer |
• • – |
2022-01-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
681,302 |
|
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-05-29 |
4 |
A |
$4.01 |
$822 |
D/D |
205 |
81,771 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-05-15 |
4 |
A |
$5.86 |
$820 |
D/D |
140 |
81,566 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-04-30 |
4 |
A |
$6.17 |
$821 |
D/D |
133 |
81,426 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-04-15 |
4 |
A |
$5.61 |
$819 |
D/D |
146 |
81,293 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-03-31 |
4 |
A |
$3.57 |
$818 |
D/D |
229 |
81,147 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-03-13 |
4 |
A |
$3.40 |
$819 |
D/D |
241 |
80,918 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-02-28 |
4 |
A |
$5.78 |
$821 |
D/D |
142 |
80,677 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-02-14 |
4 |
A |
$7.14 |
$821 |
D/D |
115 |
80,535 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-01-31 |
4 |
A |
$5.82 |
$821 |
D/D |
141 |
80,420 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2020-01-15 |
4 |
A |
$6.70 |
$4,636 |
D/D |
692 |
80,279 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-11-15 |
4 |
A |
$5.12 |
$604 |
D/D |
118 |
79,587 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-10-31 |
4 |
A |
$5.96 |
$793 |
D/D |
133 |
79,469 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-10-15 |
4 |
A |
$7.12 |
$797 |
D/D |
112 |
79,336 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-09-30 |
4 |
A |
$7.48 |
$800 |
D/D |
107 |
79,224 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-09-13 |
4 |
A |
$9.28 |
$789 |
D/D |
85 |
79,117 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-08-30 |
4 |
A |
$8.13 |
$797 |
D/D |
98 |
79,032 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-08-15 |
4 |
A |
$8.02 |
$794 |
D/D |
99 |
78,934 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-07-31 |
4 |
A |
$7.11 |
$796 |
D/D |
112 |
78,835 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-07-15 |
4 |
A |
$7.85 |
$801 |
D/D |
102 |
78,723 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-06-28 |
4 |
A |
$7.86 |
$794 |
D/D |
101 |
78,621 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-06-14 |
4 |
A |
$8.25 |
$792 |
D/D |
96 |
78,520 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-05-31 |
4 |
A |
$4.58 |
$797 |
D/D |
174 |
78,424 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Scientific Officer |
• – – |
2019-05-15 |
4 |
A |
$5.58 |
$798 |
D/D |
143 |
78,250 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
